Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.235 CAD | -6.00% | -6.00% | -41.98% |
Mar. 22 | Diagnos Raises C$182,000 in the Final Tranche of a Private Placement of Share Units | MT |
Mar. 22 | DIAGNOS Inc. announced that it has received CAD 0.578 million in funding | CI |
Sales 2024 * | 225K 165K | Sales 2025 * | 4.18M 3.07M | Capitalization | 17.84M 13.11M |
---|---|---|---|---|---|
Net income 2024 * | - | Net income 2025 * | - | EV / Sales 2024 * | 79.3 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 4.27 x |
P/E ratio 2024 * |
-5.88
x | P/E ratio 2025 * |
-11.8
x | Employees | 22 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 85.17% |
1 day | -6.00% | ||
1 week | -6.00% | ||
Current month | -14.55% | ||
1 month | -17.54% | ||
3 months | -39.74% | ||
6 months | -55.66% | ||
Current year | -41.98% |
Managers | Title | Age | Since |
---|---|---|---|
André Larente
CEO | Chief Executive Officer | - | 00-09-20 |
Director of Finance/CFO | - | 08-04-30 | |
Chief Operating Officer | - | 16-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Francis Bellido
BRD | Director/Board Member | - | 19-11-26 |
André Larente
CEO | Chief Executive Officer | - | 00-09-20 |
Vincent Duhamel
CHM | Chairman | 59 | 20-09-27 |
Date | Price | Change | Volume |
---|---|---|---|
24-03-27 | 0.235 | -6.00% | 98,800 |
24-03-26 | 0.25 | +4.17% | 72,200 |
24-03-25 | 0.24 | -2.04% | 52,973 |
24-03-22 | 0.245 | -2.00% | 53,500 |
24-03-21 | 0.25 | 0.00% | 146,001 |
Delayed Quote Toronto S.E., March 27, 2024 at 03:50 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-41.98% | 13.13M | |
-2.84% | 214B | |
+16.66% | 175B | |
+2.34% | 167B | |
+6.59% | 102B | |
+10.79% | 81.08B | |
+26.21% | 77.94B | |
-2.91% | 73.72B | |
-19.58% | 53.45B | |
+5.52% | 50.25B |